Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2015 Results

Conference Call and Webcast Scheduled For Thursday, October 29, 2015

Oct 22, 2015, 13:00 ET from Neurocrine Biosciences, Inc.

SAN DIEGO, Oct. 22, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its third quarter 2015 financial results after the Nasdaq market closes on Thursday, October 29, 2015.  Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Thursday afternoon, October 29, 2015 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing 866-952-1907 (US) or 785-424-1826 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600.  A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 800-839-5127 (US) or 402-220-2692 (International) using the conference ID: NBIX. The call will be archived for one month.

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. 

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at


SOURCE Neurocrine Biosciences, Inc.